FAQ: Branded Legacy's Intranasal Drug Delivery Platform Provisional Patent Filing

What is the main announcement from Branded Legacy, Inc.?

Branded Legacy’s subsidiary BioLegacy Evaluative Group has filed a provisional patent application with the U.S. Patent and Trademark Office for an air-driven intranasal drug delivery device designed for stable and reconstitutable medicaments.

What type of device has been patented and how does it work?

The device is an ‘Air-Driven Unitary Intranasal Drug Delivery Device’ that uses air power to provide precise, reliable, and cost-effective intranasal dosing for medications, including both stable formulations and unstable drugs requiring on-demand reconstitution.

Why is this intranasal delivery platform significant?

This platform offers precise, reliable, and cost-effective dosing for critical medications, positioning Branded Legacy as a leader in addressing public health challenges through innovative drug delivery technology.

What types of medications can this device deliver?

The device is designed to deliver both stable formulations such as naloxone and unstable drugs that require on-demand reconstitution before administration.

Who is involved in developing this technology?

The technology is being developed by BioLegacy Evaluative Group Inc., a subsidiary of Branded Legacy, Inc., through strategic collaborations with leading institutions including McMaster University and Stanford University.

Where does Branded Legacy have manufacturing capabilities?

Branded Legacy operates a state-of-the-art GMP manufacturing facility in Vancouver, which provides advanced production capabilities for developing cutting-edge products.

What is Branded Legacy’s primary business focus?

Branded Legacy is a holding company focused on pioneering solutions in addiction treatment and harm reduction through innovative life sciences and wellness solutions.

Where can I find more information about this announcement?

For more information, you can view the full press release at https://ibn.fm/4ACgT or visit the company’s website at https://BrandedLegacy.com.

What stage is this patent application currently in?

The company has filed a provisional patent application with the U.S. Patent and Trademark Office, which is an initial step in the patent process that establishes an early filing date.